In the multivariate analysis, IgA aB2GPI was an independent risk factor for the development of early graft loss and delayed graft function but was unable to prove IgA aB2GPI as an independent risk factor for thrombosis graft loss. The gene discussed is CD79A; the disease is deep vein thrombosis.